658 related articles for article (PubMed ID: 23216713)
21. Men's perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer.
McPartland TS; Weaver BA; Lee SK; Koutsky LA
J Am Coll Health; 2005; 53(5):225-30. PubMed ID: 15813233
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
23. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus and genital cancer.
Rapose A
Indian J Dermatol Venereol Leprol; 2009; 75(3):236-43; quiz 243-4. PubMed ID: 19439875
[TBL] [Abstract][Full Text] [Related]
25. Acceptability of human papillomavirus vaccine for males: a review of the literature.
Liddon N; Hood J; Wynn BA; Markowitz LE
J Adolesc Health; 2010 Feb; 46(2):113-23. PubMed ID: 20113917
[TBL] [Abstract][Full Text] [Related]
26. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
Stanley M
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
[TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus Awareness in Haiti: Preparing for a National HPV Vaccination Program.
Gichane MW; Calo WA; McCarthy SH; Walmer KA; Boggan JC; Brewer NT
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):96-101. PubMed ID: 27498340
[TBL] [Abstract][Full Text] [Related]
28. [Human Papillomavirus infection and vaccination: knowledge and attitudes of Italian general practitioners].
Signorelli C; Odone A; Pezzetti F; Spagnoli F; Visciarelli S; Ferrari A; Camia P; Latini C; Ciorba V; Agodi A; Barchitta M; Scotti S; Misericordia P; Pasquarella C
Epidemiol Prev; 2014; 38(6 Suppl 2):88-92. PubMed ID: 25759351
[TBL] [Abstract][Full Text] [Related]
29. Reducing the health burden of HPV infection through vaccination.
Soper D
Infect Dis Obstet Gynecol; 2006; 2006 Suppl():83084. PubMed ID: 16967913
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus disease in adolescents: management and prevention.
Widdice LE
Adolesc Med State Art Rev; 2012 Apr; 23(1):192-206, xii-xiii. PubMed ID: 22764563
[TBL] [Abstract][Full Text] [Related]
31. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
32. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
[TBL] [Abstract][Full Text] [Related]
33. Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site.
Gunasekaran B; Jayasinghe Y; Fenner Y; Moore EE; Wark JD; Fletcher A; Tabrizi SN; Garland SM
Sex Transm Infect; 2013 Jun; 89(4):327-9. PubMed ID: 23047877
[TBL] [Abstract][Full Text] [Related]
34. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women.
Rosenthal D; Dyson S; Pitts M; Garland S
Women Health; 2007; 45(2):59-73. PubMed ID: 18019286
[TBL] [Abstract][Full Text] [Related]
35. Trends in Male and Female Genital Warts Among Adolescents in a Safety-Net Health Care System 2004-2013: Correlation With Introduction of Female and Male Human Papillomavirus Vaccination.
Perkins RB; Legler A; Hanchate A
Sex Transm Dis; 2015 Dec; 42(12):665-8. PubMed ID: 26562694
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer.
Chelimo C; Wouldes TA; Cameron LD; Elwood JM
J Infect; 2013 Mar; 66(3):207-17. PubMed ID: 23103285
[TBL] [Abstract][Full Text] [Related]
37. Intention to obtain human papillomavirus vaccination among taiwanese undergraduate women.
Hsu YY; Fetzer SJ; Hsu KF; Chang YY; Huang CP; Chou CY
Sex Transm Dis; 2009 Nov; 36(11):686-92. PubMed ID: 19652629
[TBL] [Abstract][Full Text] [Related]
38. A brief history of economic evaluation for human papillomavirus vaccination policy.
Beutels P; Jit M
Sex Health; 2010 Sep; 7(3):352-8. PubMed ID: 20719227
[TBL] [Abstract][Full Text] [Related]
39. Male human papillomavirus vaccine acceptance is enhanced by a brief intervention that emphasizes both male-specific vaccine benefits and altruistic motives.
Bonafide KE; Vanable PA
Sex Transm Dis; 2015 Feb; 42(2):76-80. PubMed ID: 25585065
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus, cervical cancer, and the vaccines.
Tovar JM; Bazaldua OV; Vargas L; Reile E
Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
